Sandhani Life Insurance Company Limited (DSE:SANDHANINS)
21.90
-0.10 (-0.45%)
At close: Aug 11, 2025
Elevation Oncology Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2015 - 2019 |
Premiums & Annuity Revenue | 2,365 | 2,403 | 2,376 | 2,150 | 1,844 | 1,822 | Upgrade |
Total Interest & Dividend Income | 629.17 | 501.29 | 530.44 | 641.47 | 798.97 | 817.44 | Upgrade |
Gain (Loss) on Sale of Investments | 12.77 | 12.77 | 32.58 | 91.55 | 10.88 | 13.49 | Upgrade |
Other Revenue | -72.22 | 22.53 | 9.96 | 54.59 | 69.55 | 6.77 | Upgrade |
Total Revenue | 2,935 | 2,939 | 2,949 | 2,938 | 2,723 | 2,659 | Upgrade |
Revenue Growth (YoY) | -2.09% | -0.33% | 0.38% | 7.87% | 2.42% | 11.25% | Upgrade |
Policy Benefits | 2,240 | 2,198 | 2,224 | 2,396 | 2,030 | 2,186 | Upgrade |
Policy Acquisition & Underwriting Costs | 280.2 | 328.96 | 380.98 | 398.12 | 290.15 | 285.99 | Upgrade |
Depreciation & Amortization | 44.16 | 44.16 | 46.65 | 39.85 | 37.97 | 39.29 | Upgrade |
Selling, General & Administrative | 159.53 | 152.85 | 156.78 | 105.12 | 117.96 | 125 | Upgrade |
Provision for Bad Debts | - | - | 3.1 | 5.86 | 5 | 6 | Upgrade |
Other Operating Expenses | -4.39 | -3.25 | -1.65 | 260.16 | -30.27 | -30.89 | Upgrade |
Total Operating Expenses | 2,990 | 2,991 | 3,121 | 3,384 | 2,704 | 2,865 | Upgrade |
Operating Income | -55.11 | -51.4 | -171.47 | -446.01 | 19.42 | -205.91 | Upgrade |
Interest Expense | -1.32 | -1.32 | -1.08 | -5.65 | - | - | Upgrade |
Other Non Operating Income (Expenses) | -8.93 | -8.93 | -79.86 | -12.03 | -5.85 | -23.73 | Upgrade |
EBT Excluding Unusual Items | -65.36 | -61.66 | -252.41 | -463.69 | 13.57 | -229.64 | Upgrade |
Gain (Loss) on Sale of Assets | 7.52 | 7.52 | 4.73 | 1.84 | 3.67 | 7.46 | Upgrade |
Other Unusual Items | -0.62 | - | - | - | - | - | Upgrade |
Pretax Income | -58.46 | -54.13 | -247.67 | -461.85 | 17.24 | -222.18 | Upgrade |
Income Tax Expense | 140.52 | 43.33 | 52.42 | 53.32 | 88.07 | 114.63 | Upgrade |
Earnings From Continuing Ops. | -198.98 | -97.47 | -300.09 | -515.17 | -70.84 | -336.81 | Upgrade |
Minority Interest in Earnings | -0 | -0 | -0 | -0 | -0 | 0 | Upgrade |
Net Income | -198.98 | -97.47 | -300.09 | -515.17 | -70.84 | -336.81 | Upgrade |
Net Income to Common | -198.98 | -97.47 | -300.09 | -515.17 | -70.84 | -336.81 | Upgrade |
Shares Outstanding (Basic) | 110 | 110 | 110 | 110 | 110 | 110 | Upgrade |
Shares Outstanding (Diluted) | 110 | 110 | 110 | 110 | 110 | 110 | Upgrade |
EPS (Basic) | -1.81 | -0.89 | -2.74 | -4.70 | -0.65 | -3.07 | Upgrade |
EPS (Diluted) | -1.81 | -0.89 | -2.74 | -4.70 | -0.65 | -3.07 | Upgrade |
Free Cash Flow | -55.03 | -58.37 | -190.53 | 117.09 | 578.57 | -355.57 | Upgrade |
Free Cash Flow Per Share | -0.50 | -0.53 | -1.74 | 1.07 | 5.27 | -3.24 | Upgrade |
Dividend Per Share | 1.200 | 1.200 | 1.200 | 1.200 | 1.200 | 1.200 | Upgrade |
Dividend Growth | - | - | - | - | - | -20.00% | Upgrade |
Operating Margin | -1.88% | -1.75% | -5.81% | -15.18% | 0.71% | -7.74% | Upgrade |
Profit Margin | -6.78% | -3.32% | -10.18% | -17.54% | -2.60% | -12.67% | Upgrade |
Free Cash Flow Margin | -1.88% | -1.99% | -6.46% | 3.99% | 21.24% | -13.37% | Upgrade |
EBITDA | -21.96 | -16.39 | -132.56 | -407.4 | 57.39 | -166.62 | Upgrade |
EBITDA Margin | -0.75% | -0.56% | -4.50% | -13.87% | 2.11% | -6.27% | Upgrade |
D&A For EBITDA | 33.15 | 35.01 | 38.91 | 38.61 | 37.97 | 39.29 | Upgrade |
EBIT | -55.11 | -51.4 | -171.47 | -446.01 | 19.42 | -205.91 | Upgrade |
EBIT Margin | -1.88% | -1.75% | -5.81% | -15.18% | 0.71% | -7.74% | Upgrade |
Effective Tax Rate | - | - | - | - | 510.96% | - | Upgrade |
Revenue as Reported | 6,839 | - | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.